Equine Proliferative Enteropathy in Weanling Foals on A German Breeding Farm: Clinical Course, Treatment and Long-Term Outcome.
Abstract: The goal of the current report was to describe the clinical signs, therapy and outcome of foals with suspected equine proliferative enteropathy (EPE) due to an infection with Lawsonia intracellularis. Forty foals, born on the same breeding farm, were diagnosed with suspected clinical EPE between September 2019 and January 2020. Data of these cases were analyzed retrospectively regarding the course of the disease, treatment, outcome and long-term prognosis. All horses, including randomly selected control horses, were reassessed about nine months after the suspicion of EPE. The horses affected were between 5 and 10 months of age. Fever was the most common clinical sign. Hypoproteinemia was shown consistently in all cases. Seroconversion was detected in all horses affected, while fecal shedding of Lawsonia intracellularis via qualitative real-time polymerase chain reaction was only found in 21 cases. Treatment was based on tetracyclines and the administration of equine plasma IV. A total of 39 of 40 foals survived EPE. No long-term effects in terms of poor body condition or abnormal blood values were observed. If diagnosed and treated early, EPE can generally be described as a disease with a good prognosis and no long-term effects in Warmblood horses.
Copyright © 2022. Published by Elsevier Inc.
Publication Date: 2022-01-21 PubMed ID: 35074397DOI: 10.1016/j.jevs.2022.103873Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Case Reports
- Research Support
- Non-U.S. Gov't
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research covers a study on the impacts, treatment, and long-term outcomes of equine proliferative enteropathy (EPE) on weanling foals in a breeding farm in Germany. It concludes that early diagnosis and treatment of EPE can lead to a favorable prognosis with no long-term effects.
Understanding the Research
- The research revolves around a specific equine disease known as Equine Proliferative Enteropathy (EPE), a bacterial infection by Lawsonia intracellularis affecting foals, particularly those in weaning age. EPE leads to thickening of the intestines and can cause fever, colic, and weight loss.
- From 2019 to 2020, the researchers observed 40 foals on the same breeding farm that were suspected of suffering from EPE. These cases provided data for their research, which was analyzed retrospectively to track the disease’s progression, treatment, and outcome, as well as the long-term prognosis.
Clinical Signs and Diagnosis
- The most common symptom observed in the affected foals was fever. Hypoproteinemia, a condition that results from low protein levels in the blood, was consistently found across all identified EPE cases.
- Seroconversion was detected in all affected horses, which indicates the horse’s immune response to the Lawsonia intracellularis infection. However, the actual shedding of the bacteria in the feces, identified through a real-time polymerase chain reaction test, was found only in more than half the cases (21 of 40).
Treatment and Outcome
- All detected cases of EPE were treated with tetracyclines, a type of antibiotic, combined with the administration of equine plasma IV, which helps replace proteins lost due to the disease.
- The treatment proved to be largely successful, with 39 out of 40 foals surviving the bout of EPE.
Long-term Prognosis
- The study found no long-term negative effects on the horses in terms of body condition or abnormal blood values. This suggests that if detected and treated early, EPE can generally yield a good prognosis with no lasting impact on the health or condition of the affected Warmblood horses.
Key Findings and Conclusion
- This study provides valuable insight into understanding, diagnosing, and treating EPE in a farm setting, especially in cases affecting Warmblood weanling foals.
- The absence of severe long-term effects reveals the potential for successful treatment and recovery of foals from EPE.
- The optimal response to EPE primarily entails early detection and appropriate treatment using a combination of antibiotics and equine plasma IV.
Cite This Article
APA
Dohrmann J, Hildebrand F, Straub J, Wadephul R, Pusterla N, Freise F, Venner M.
(2022).
Equine Proliferative Enteropathy in Weanling Foals on A German Breeding Farm: Clinical Course, Treatment and Long-Term Outcome.
J Equine Vet Sci, 111, 103873.
https://doi.org/10.1016/j.jevs.2022.103873 Publication
Researcher Affiliations
- Clinic for Horses, University of Veterinary Medicine Hanover, Foundation, Hanover, Germany.
- Clinic for Horses, Lewitz Stud, Neustadt-Glewe, Germany.
- Clinic for Horses, University of Veterinary Medicine Hanover, Foundation, Hanover, Germany.
- Clinic for Horses, University of Veterinary Medicine Hanover, Foundation, Hanover, Germany.
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis.
- Epidemiology and Information Processing, Institute for Biometry, University of Veterinary Medicine Hanover, Foundation, Hanover, Germany.
- Equine Clinic, Destedt, Germany. Electronic address: MVenner@gmx.de.
MeSH Terms
- Animals
- Desulfovibrionaceae Infections / diagnosis
- Desulfovibrionaceae Infections / veterinary
- Farms
- Horse Diseases / diagnosis
- Horses
- Intestinal Diseases / diagnosis
- Intestinal Diseases / veterinary
- Lawsonia Bacteria
- Retrospective Studies
Conflict of Interest Statement
Declaration of Competing Interest No competing interests have been declared.
Citations
This article has been cited 4 times.- Hardefeldt L, Thomas K, Page S, Norris J, Browning G, El Hage C, Stewart A, Gilkerson J, Muscatello G, Verwilghen D, van Galen G, Bauquier J, Cuming R, Reynolds B, Whittaker C, Wilkes E, Clulow J, Burden C, Begg L. Antimicrobial prescribing guidelines for horses in Australia. Aust Vet J 2025 Dec;103(12):781-889.
- Matté YA, Baldasso DZ, Rezende MA, Lui JFM, Seibel AC, Guizzo JA, Frandoloso R, Kreutz LC. Immunological insights into the occurrence of Lawsonia intracellularis in horses from southern Brazil using flow cytometry. Vet World 2025 Apr;18(4):755-762.
- Fikri F, Hendrawan D, Wicaksono AP, Purnomo A, Khairani S, Chhetri S, Maslamama ST, Purnama MTE. Incidence, risk factors, and therapeutic management of equine colic in Lamongan, Indonesia. Vet World 2023;16(7):1408-1414.
- Niwa H, Higuchi T, Fujii S, Kinoshita Y, Uchida-Fujii E, Sueyoshi M, Nukada T, Ueno T. Prevalence of equine proliferative enteropathy in Hidaka district, Hokkaido, over five seasons. J Equine Sci 2022 Dec;33(4):71-74.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists